Cronos Group
Altria Invests $2.4 Billion in Cronos Group
In an effort to develop new product lines and expand large-scale cultivation capabilities, Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) just…
Cronos – No Cash, No Deal….. Tough Times
Bottom Line The leak of acquisition talks between Cronos and Altria is a classic tactic used by companies to support…
Canadian Pot Companies Issue Messages To Shareholders Following Legalization
October 17 was a historic turning point for marijuana in Canada, but for many companies across the cannabis industry, legalization…
Cronos Group Partners With Technion To Research Cannabis Skin Care Treatments
Marijuana may be legal at a recreational level in Canada thanks to the passage of the Cannabis Act, but that…
One Step Forward, Two Back: Legal Canadian Marijuana Workers Could Face Drug Trafficker Treatment in US
Federal laws stand in the way of the United States extending reasonable treatment to workers and investors who plan to…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (September 8)
Cannabis Demand Could be Double Government Estimates Bottom Line: If per person consumption in Canada looks anything like Colorado, demand…
Canopy’s Shares Rise 8.2% to Market Cap of $14.36 Billion
Canopy Growth Corp. (TSE: WEED) currently has a higher market cap than some more well-known and well-established stocks on the…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (Sept. 1)
Citron Research Sour on Cronos Group In our view Andrew Left from Citron knows how to make a flashy entrance…
Citron Grasping at Straws – Cronos Will Endure
Citron Comes for Cronos Citron Research, a well-known US short seller finally decided to enter the cannabis ring with a…